Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.

Felix AS, Cohn DE, Brasky TM, Zaino R, Park K, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Randall ME, Brinton LA.

Am J Obstet Gynecol. 2018 Nov;219(5):459.e1-459.e11. doi: 10.1016/j.ajog.2018.08.002. Epub 2018 Aug 7.

PMID:
30096321
2.

HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells.

James NE, Cantillo E, Oliver MT, Rowswell-Turner RB, Ribeiro JR, Kim KK, Chichester CO 3rd, DiSilvestro PA, Moore RG, Singh RK, Yano N, Zhao TC.

Clin Exp Immunol. 2018 Sep;193(3):327-340. doi: 10.1111/cei.13153.

PMID:
29745428
3.

Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix.

Ribeiro JR, Gaudet HM, Khan M, Schorl C, James NE, Oliver MT, DiSilvestro PA, Moore RG, Yano N.

Front Oncol. 2018 Jan 22;7:332. doi: 10.3389/fonc.2017.00332. eCollection 2017.

4.

Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.

Felix AS, Brasky TM, Cohn DE, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel C, Boggess JF, Pearl ML, Ioffe OB, Deng W, Miller DS, Brinton LA.

Int J Cancer. 2018 Mar 15;142(6):1102-1115. doi: 10.1002/ijc.31127. Epub 2017 Nov 6.

5.

Talking to the people that really matter about their participation in pandemic clinical research: A qualitative study in four European countries.

Gobat NH, Gal M, Butler CC, Webb SAR, Francis NA, Stanton H, Anthierens S, Bastiaens H, Godycki-Ćwirko M, Kowalczyk A, Pons-Vigués M, Pujol-Ribera E, Berenguera A, Watkins A, Sukumar P, Moore RG, Hood K, Nichol A.

Health Expect. 2018 Feb;21(1):387-395. doi: 10.1111/hex.12634. Epub 2017 Sep 27.

6.

HfSe2 and ZrSe2: Two-dimensional semiconductors with native high-κ oxides.

Mleczko MJ, Zhang C, Lee HR, Kuo HH, Magyari-Köpe B, Moore RG, Shen ZX, Fisher IR, Nishi Y, Pop E.

Sci Adv. 2017 Aug 11;3(8):e1700481. doi: 10.1126/sciadv.1700481. eCollection 2017 Aug.

7.

Femtosecond electron-phonon lock-in by photoemission and x-ray free-electron laser.

Gerber S, Yang SL, Zhu D, Soifer H, Sobota JA, Rebec S, Lee JJ, Jia T, Moritz B, Jia C, Gauthier A, Li Y, Leuenberger D, Zhang Y, Chaix L, Li W, Jang H, Lee JS, Yi M, Dakovski GL, Song S, Glownia JM, Nelson S, Kim KW, Chuang YD, Hussain Z, Moore RG, Devereaux TP, Lee WS, Kirchmann PS, Shen ZX.

Science. 2017 Jul 7;357(6346):71-75. doi: 10.1126/science.aak9946.

PMID:
28684521
8.

Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence.

Brasky TM, Felix AS, Cohn DE, McMeekin DS, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Park KJ, Ali S, Brinton LA.

J Natl Cancer Inst. 2017 Mar 1;109(3):1-10. doi: 10.1093/jnci/djw251.

9.

Predictors for lymph nodes involvement in low risk endometrial cancer.

Kadan Y, Calvino AS, Katz A, Katz S, Moore RG.

J Obstet Gynaecol. 2017 May;37(4):514-518. doi: 10.1080/01443615.2017.1281895. Epub 2017 Mar 24.

PMID:
28339318
10.

Assessment of serum HE4 levels throughout the normal menstrual cycle.

Moore RG, Plante B, Hartnett E, Mitchel J, Raker CA, Vitek W, Eklund E, Lambert-Messerlian G.

Am J Obstet Gynecol. 2017 Jul;217(1):53.e1-53.e9. doi: 10.1016/j.ajog.2017.02.029. Epub 2017 Feb 22.

PMID:
28237871
11.

Coexistence of Replica Bands and Superconductivity in FeSe Monolayer Films.

Rebec SN, Jia T, Zhang C, Hashimoto M, Lu DH, Moore RG, Shen ZX.

Phys Rev Lett. 2017 Feb 10;118(6):067002. doi: 10.1103/PhysRevLett.118.067002. Epub 2017 Feb 10.

PMID:
28234508
12.

Ubiquitous strong electron-phonon coupling at the interface of FeSe/SrTiO3.

Zhang C, Liu Z, Chen Z, Xie Y, He R, Tang S, He J, Li W, Jia T, Rebec SN, Ma EY, Yan H, Hashimoto M, Lu D, Mo SK, Hikita Y, Moore RG, Hwang HY, Lee D, Shen Z.

Nat Commun. 2017 Feb 10;8:14468. doi: 10.1038/ncomms14468.

13.

Superconducting Gap Anisotropy in Monolayer FeSe Thin Film.

Zhang Y, Lee JJ, Moore RG, Li W, Yi M, Hashimoto M, Lu DH, Devereaux TP, Lee DH, Shen ZX.

Phys Rev Lett. 2016 Sep 9;117(11):117001. doi: 10.1103/PhysRevLett.117.117001. Epub 2016 Sep 8.

PMID:
27661715
14.

Origin of the low critical observing temperature of the quantum anomalous Hall effect in V-doped (Bi, Sb)2Te3 film.

Li W, Claassen M, Chang CZ, Moritz B, Jia T, Zhang C, Rebec S, Lee JJ, Hashimoto M, Lu DH, Moore RG, Moodera JS, Devereaux TP, Shen ZX.

Sci Rep. 2016 Sep 7;6:32732. doi: 10.1038/srep32732.

15.

HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.

Ribeiro JR, Schorl C, Yano N, Romano N, Kim KK, Singh RK, Moore RG.

J Ovarian Res. 2016 May 17;9(1):28. doi: 10.1186/s13048-016-0240-0.

16.

Invited Article: High resolution angle resolved photoemission with tabletop 11 eV laser.

He Y, Vishik IM, Yi M, Yang S, Liu Z, Lee JJ, Chen S, Rebec SN, Leuenberger D, Zong A, Jefferson CM, Moore RG, Kirchmann PS, Merriam AJ, Shen ZX.

Rev Sci Instrum. 2016 Jan;87(1):011301. doi: 10.1063/1.4939759.

17.

Persistent order due to transiently enhanced nesting in an electronically excited charge density wave.

Rettig L, Cortés R, Chu JH, Fisher IR, Schmitt F, Moore RG, Shen ZX, Kirchmann PS, Wolf M, Bovensiepen U.

Nat Commun. 2016 Jan 25;7:10459. doi: 10.1038/ncomms10459.

18.

Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers.

Kim KK, Han A, Yano N, Ribeiro JR, Lokich E, Singh RK, Moore RG.

Sci Rep. 2015 Nov 16;5:15911. doi: 10.1038/srep15911.

19.

Antitumor Activity of 3-Indolylmethanamines 31B and PS121912.

Guthrie ML, Sidhu PS, Hill EK, Horan TC, Nandhikonda P, Teske KA, Yuan NY, Sidorko M, Rodali R, Cook JM, Han L, Silvaggi NR, Bikle DD, Moore RG, Singh RK, Arnold LA.

Anticancer Res. 2015 Nov;35(11):6001-7.

20.

Levels of antimüllerian hormone in serum during the normal menstrual cycle.

Lambert-Messerlian G, Plante B, Eklund EE, Raker C, Moore RG.

Fertil Steril. 2016 Jan;105(1):208-13.e1. doi: 10.1016/j.fertnstert.2015.09.033. Epub 2015 Oct 23.

PMID:
26477497
21.

Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells.

Kim KK, Abelman S, Yano N, Ribeiro JR, Singh RK, Tipping M, Moore RG.

Sci Rep. 2015 Oct 15;5:14296. doi: 10.1038/srep14296.

22.

Templated polymers enable selective capture and release of lysophosphatidic acid in human plasma via optimization of non-covalent binding to functional monomers.

Wang J, Sibrian-Vazquez M, Escobedo JO, Wang L, Chu YH, Moore RG, Strongin RM.

Analyst. 2015 Nov 21;140(22):7572-7. doi: 10.1039/c5an01597a.

23.

Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic mass.

Lokich E, Palisoul M, Romano N, Craig Miller M, Robison K, Stuckey A, DiSilvestro P, Mathews C, Granai CO, Lambert-Messerlian G, Moore RG.

Gynecol Oncol. 2015 Nov;139(2):248-52. doi: 10.1016/j.ygyno.2015.09.010. Epub 2015 Sep 11.

24.

Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial.

Felix AS, Scott McMeekin D, Mutch D, Walker JL, Creasman WT, Cohn DE, Ali S, Moore RG, Downs LS, Ioffe OB, Park KJ, Sherman ME, Brinton LA.

Gynecol Oncol. 2015 Oct;139(1):70-6. doi: 10.1016/j.ygyno.2015.08.022. Epub 2015 Sep 1.

25.

Observation of universal strong orbital-dependent correlation effects in iron chalcogenides.

Yi M, Liu ZK, Zhang Y, Yu R, Zhu JX, Lee JJ, Moore RG, Schmitt FT, Li W, Riggs SC, Chu JH, Lv B, Hu J, Hashimoto M, Mo SK, Hussain Z, Mao ZQ, Chu CW, Fisher IR, Si Q, Shen ZX, Lu DH.

Nat Commun. 2015 Jul 23;6:7777. doi: 10.1038/ncomms8777.

26.

Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial.

Felix AS, Brinton LA, McMeekin DS, Creasman WT, Mutch D, Cohn DE, Walker JL, Moore RG, Downs LS, Soslow RA, Zaino R, Sherman ME.

J Natl Cancer Inst. 2015 Jun 18;107(9). pii: djv158. doi: 10.1093/jnci/djv158. Print 2015 Sep.

27.

Direct characterization of photoinduced lattice dynamics in BaFe2As2.

Gerber S, Kim KW, Zhang Y, Zhu D, Plonka N, Yi M, Dakovski GL, Leuenberger D, Kirchmann PS, Moore RG, Chollet M, Glownia JM, Feng Y, Lee JS, Mehta A, Kemper AF, Wolf T, Chuang YD, Hussain Z, Kao CC, Moritz B, Shen ZX, Devereaux TP, Lee WS.

Nat Commun. 2015 Jun 8;6:7377. doi: 10.1038/ncomms8377.

28.

Thickness-Dependent Coherent Phonon Frequency in Ultrathin FeSe/SrTiO₃ Films.

Yang S, Sobota JA, Leuenberger D, Kemper AF, Lee JJ, Schmitt FT, Li W, Moore RG, Kirchmann PS, Shen ZX.

Nano Lett. 2015 Jun 10;15(6):4150-4. doi: 10.1021/acs.nanolett.5b01274. Epub 2015 Jun 1.

PMID:
26027951
29.

The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells.

Wang Y, Han A, Chen E, Singh RK, Chichester CO, Moore RG, Singh AP, Vorsa N.

Int J Oncol. 2015 May;46(5):1924-34. doi: 10.3892/ijo.2015.2931. Epub 2015 Mar 17.

30.

Interface ferroelectric transition near the gap-opening temperature in a single-unit-cell FeSe film grown on Nb-Doped SrTiO3 substrate.

Cui YT, Moore RG, Zhang AM, Tian Y, Lee JJ, Schmitt FT, Zhang WH, Li W, Yi M, Liu ZK, Hashimoto M, Zhang Y, Lu DH, Devereaux TP, Wang LL, Ma XC, Zhang QM, Xue QK, Lee DH, Shen ZX.

Phys Rev Lett. 2015 Jan 23;114(3):037002. Epub 2015 Jan 22.

PMID:
25659015
31.

Predictive factors for the presence of malignant transformation of pelvic endometriosis.

Kadan Y, Fiascone S, McCourt C, Raker C, Granai CO, Steinhoff M, Moore RG.

Eur J Obstet Gynecol Reprod Biol. 2015 Feb;185:23-7. doi: 10.1016/j.ejogrb.2014.11.029. Epub 2014 Dec 2.

PMID:
25522113
32.

Spiroguanidine rhodamines as fluorogenic probes for lysophosphatidic acid.

Wang L, Sibrian-Vazquez M, Escobedo JO, Wang J, Moore RG, Strongin RM.

Chem Commun (Camb). 2015 Jan 31;51(9):1697-700. doi: 10.1039/c4cc08818b.

33.

Combining clinical assessment and the Risk of Ovarian Malignancy Algorithm for the prediction of ovarian cancer.

Moore RG, Hawkins DM, Miller MC, Landrum LM, Gajewski W, Ball JJ, Allard WJ, Skates SJ.

Gynecol Oncol. 2014 Dec;135(3):547-51. doi: 10.1016/j.ygyno.2014.10.017. Epub 2014 Oct 23.

PMID:
25449569
34.

Interfacial mode coupling as the origin of the enhancement of T(c) in FeSe films on SrTiO3.

Lee JJ, Schmitt FT, Moore RG, Johnston S, Cui YT, Li W, Yi M, Liu ZK, Hashimoto M, Zhang Y, Lu DH, Devereaux TP, Lee DH, Shen ZX.

Nature. 2014 Nov 13;515(7526):245-8. doi: 10.1038/nature13894.

PMID:
25391962
35.

Direct spectroscopic evidence for phase competition between the pseudogap and superconductivity in Bi2Sr2CaCu2O(8+δ).

Hashimoto M, Nowadnick EA, He RH, Vishik IM, Moritz B, He Y, Tanaka K, Moore RG, Lu D, Yoshida Y, Ishikado M, Sasagawa T, Fujita K, Ishida S, Uchida S, Eisaki H, Hussain Z, Devereaux TP, Shen ZX.

Nat Mater. 2015 Jan;14(1):37-42. doi: 10.1038/nmat4116. Epub 2014 Nov 2.

36.

HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocation.

Lokich E, Singh RK, Han A, Romano N, Yano N, Kim K, Moore RG.

Sci Rep. 2014 Jun 30;4:5500. doi: 10.1038/srep05500.

37.

Long-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy alone.

Robison K, Roque D, McCourt C, Stuckey A, DiSilvestro PA, Sung CJ, Steinhoff M, Granai CO, Moore RG.

Gynecol Oncol. 2014 Jun;133(3):416-20. doi: 10.1016/j.ygyno.2014.03.010. Epub 2014 Mar 11.

PMID:
24631445
38.

Large-amplitude spin dynamics driven by a THz pulse in resonance with an electromagnon.

Kubacka T, Johnson JA, Hoffmann MC, Vicario C, de Jong S, Beaud P, Grübel S, Huang SW, Huber L, Patthey L, Chuang YD, Turner JJ, Dakovski GL, Lee WS, Minitti MP, Schlotter W, Moore RG, Hauri CP, Koohpayeh SM, Scagnoli V, Ingold G, Johnson SL, Staub U.

Science. 2014 Mar 21;343(6177):1333-6. doi: 10.1126/science.1242862. Epub 2014 Mar 6.

PMID:
24603154
39.

A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer.

Krivak TC, Lele S, Richard S, Secord AA, Leath CA 3rd, Brower SL, Tian C, Moore RG.

Am J Obstet Gynecol. 2014 Jul;211(1):68.e1-8. doi: 10.1016/j.ajog.2014.02.009. Epub 2014 Feb 12.

40.

HE4 (WFDC2) gene overexpression promotes ovarian tumor growth.

Moore RG, Hill EK, Horan T, Yano N, Kim K, MacLaughlan S, Lambert-Messerlian G, Tseng YD, Padbury JF, Miller MC, Lange TS, Singh RK.

Sci Rep. 2014 Jan 6;4:3574. doi: 10.1038/srep03574.

41.

PT19c, Another Nonhypercalcemic Vitamin D2 Derivative, Demonstrates Antitumor Efficacy in Epithelial Ovarian and Endometrial Cancer Models.

Kawar N, Maclaughlan S, Horan TC, Uzun A, Lange TS, Kim KK, Hopson R, Singh AP, Sidhu PS, Glass KA, Shaw S, Padbury JF, Vorsa N, Arnold LA, Moore RG, Brard L, Singh RK.

Genes Cancer. 2013 Nov;4(11-12):524-34. doi: 10.1177/1947601913507575.

42.

Direct optical coupling to an unoccupied dirac surface state in the topological insulator Bi2Se3.

Sobota JA, Yang SL, Kemper AF, Lee JJ, Schmitt FT, Li W, Moore RG, Analytis JG, Fisher IR, Kirchmann PS, Devereaux TP, Shen ZX.

Phys Rev Lett. 2013 Sep 27;111(13):136802. Epub 2013 Sep 24.

PMID:
24116801
43.

Simple enrichment and analysis of plasma lysophosphatidic acids.

Wang J, Sibrian-Vazquez M, Escobedo JO, Lowry M, Wang L, Chu YH, Moore RG, Strongin RM.

Analyst. 2013 Nov 21;138(22):6852-9. doi: 10.1039/c3an01168b.

44.

A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer.

Rutherford T, Orr J Jr, Grendys E Jr, Edwards R, Krivak TC, Holloway R, Moore RG, Puls L, Tillmanns T, Schink JC, Brower SL, Tian C, Herzog TJ.

Gynecol Oncol. 2013 Nov;131(2):362-7. doi: 10.1016/j.ygyno.2013.08.009. Epub 2013 Aug 13.

45.

Speed limit of the insulator-metal transition in magnetite.

de Jong S, Kukreja R, Trabant C, Pontius N, Chang CF, Kachel T, Beye M, Sorgenfrei F, Back CH, Bräuer B, Schlotter WF, Turner JJ, Krupin O, Doehler M, Zhu D, Hossain MA, Scherz AO, Fausti D, Novelli F, Esposito M, Lee WS, Chuang YD, Lu DH, Moore RG, Yi M, Trigo M, Kirchmann P, Pathey L, Golden MS, Buchholz M, Metcalf P, Parmigiani F, Wurth W, Föhlisch A, Schüßler-Langeheine C, Dürr HA.

Nat Mater. 2013 Oct;12(10):882-6. doi: 10.1038/nmat3718. Epub 2013 Jul 28.

PMID:
23892787
46.

Origin of electrochromism in high-performing nanocomposite nickel oxide.

Lin F, Nordlund D, Weng TC, Sokaras D, Jones KM, Reed RB, Gillaspie DT, Weir DG, Moore RG, Dillon AC, Richards RM, Engtrakul C.

ACS Appl Mater Interfaces. 2013 May;5(9):3643-9. doi: 10.1021/am400105y. Epub 2013 Apr 22. Erratum in: ACS Appl Mater Interfaces. 2013 Sep 11;5(17):8820.

PMID:
23547738
47.

Real-time manifestation of strongly coupled spin and charge order parameters in stripe-ordered La(1.75)Sr(0.25)NiO(4) nickelate crystals using time-resolved resonant x-ray diffraction.

Chuang YD, Lee WS, Kung YF, Sorini AP, Moritz B, Moore RG, Patthey L, Trigo M, Lu DH, Kirchmann PS, Yi M, Krupin O, Langner M, Zhu Y, Zhou SY, Reis DA, Huse N, Robinson JS, Kaindl RA, Schoenlein RW, Johnson SL, Först M, Doering D, Denes P, Schlotter WF, Turner JJ, Sasagawa T, Hussain Z, Shen ZX, Devereaux TP.

Phys Rev Lett. 2013 Mar 22;110(12):127404. Epub 2013 Mar 20.

PMID:
25166848
48.

Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.

Brinton LA, Felix AS, McMeekin DS, Creasman WT, Sherman ME, Mutch D, Cohn DE, Walker JL, Moore RG, Downs LS, Soslow RA, Zaino R.

Gynecol Oncol. 2013 May;129(2):277-84. doi: 10.1016/j.ygyno.2013.02.023. Epub 2013 Feb 26.

49.

Measurement of coherent polarons in the strongly coupled antiferromagnetically ordered iron-chalcogenide Fe1.02Te using angle-resolved photoemission spectroscopy.

Liu ZK, He RH, Lu DH, Yi M, Chen YL, Hashimoto M, Moore RG, Mo SK, Nowadnick EA, Hu J, Liu TJ, Mao ZQ, Devereaux TP, Hussain Z, Shen ZX.

Phys Rev Lett. 2013 Jan 18;110(3):037003. Epub 2013 Jan 18.

PMID:
23373946
50.

Hole doping in Al-containing nickel oxide materials to improve electrochromic performance.

Lin F, Nordlund D, Weng TC, Moore RG, Gillaspie DT, Dillon AC, Richards RM, Engtrakul C.

ACS Appl Mater Interfaces. 2013 Jan 23;5(2):301-9. doi: 10.1021/am302097b. Epub 2013 Jan 3.

PMID:
23249159

Supplemental Content

Loading ...
Support Center